Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Vir Biotechnology Inc banner

Vir Biotechnology Inc
NASDAQ:VIR

Watchlist Manager
Vir Biotechnology Inc Logo
Vir Biotechnology Inc
NASDAQ:VIR
Watchlist
Price: 10.88 USD 2.64% Market Closed
Market Cap: $1.8B
Write Note Create Alert Ask AI

Wall St Price Targets

VIR Price Forecast
Based on 10 analysts

+87% Upside
from $10.88 today

VIR Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for VIR yet.

Vir Biotechnology Inc Competitors:
Price Targets

Revenue
Forecast

30% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat
30% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
7%
Average Beat

Over the last 7 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 8 years is 46%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
43% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

The compound annual growth rate for Gross Profit over the next 8 years is 43%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Continue VIR Research

Summary
VIR intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIR stock valuation using valuation multiples.
Wall St Estimates
VIR price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VIR's stock price target?
Price Target
20.4 USD

According to Wall Street analysts, the average 1-year price target for VIR is 20.4 USD with a low forecast of 15.15 USD and a high forecast of 31.5 USD.

What is the Revenue forecast for Vir Biotechnology Inc?
Projected CAGR
46%

Over the last 7 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 8 years is 46%.

What is the Gross Profit forecast for Vir Biotechnology Inc?
Projected CAGR
43%

The compound annual growth rate for Gross Profit over the next 8 years is 43%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.